Prince Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Prince Pharmaceutical has a total shareholder equity of NT$774.5M and total debt of NT$361.3M, which brings its debt-to-equity ratio to 46.6%. Its total assets and total liabilities are NT$1.4B and NT$636.5M respectively. Prince Pharmaceutical's EBIT is NT$25.8M making its interest coverage ratio 2.8. It has cash and short-term investments of NT$122.6M.
Key information
46.6%
Debt to equity ratio
NT$361.25m
Debt
| Interest coverage ratio | 2.8x |
| Cash | NT$122.57m |
| Equity | NT$774.47m |
| Total liabilities | NT$636.47m |
| Total assets | NT$1.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6935's short term assets (NT$391.4M) exceed its short term liabilities (NT$211.9M).
Long Term Liabilities: 6935's short term assets (NT$391.4M) do not cover its long term liabilities (NT$424.5M).
Debt to Equity History and Analysis
Debt Level: 6935's net debt to equity ratio (30.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6935's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6935's debt is not well covered by operating cash flow (17.3%).
Interest Coverage: 6935's interest payments on its debt are not well covered by EBIT (2.8x coverage).